Rogério Sarmento-Leite

Rogério Sarmento-Leite

Auto-generated profile, based on publicly available information

Rogério Sarmento-Leite

Instituto de Cardiologia, Brasil

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in JACC
Verified
Journal Article
Closed access
MUMarina Urena
Marina Urena
JWJohn G. Webb
John G. Webb
HEHelene Eltchaninoff
Helene Eltchaninoff
AMAntonio J. Muñoz-García
Antonio J. Muñoz-García
CBClaire Bouleti
Claire Bouleti
JRJosep Rodés-Cabau
Josep Rodés-Cabau

1 March 2019 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
WVWieneke Vlastra
Wieneke Vlastra
PJPilar Jimenez-Quevedo
Pilar Jimenez-Quevedo
DTDidier Tchétché
Didier Tchétché
JCJaya Chandrasekhar
Jaya Chandrasekhar
FBFabio S. de Brito
Fabio S. de Brito
RDRonak Delewi
Ronak Delewi
Background: Stroke remains one of the most devastating complications of transcatheter aortic valve implantation (TAVI). The aim of this study was to identify the incidence, timing, temporal trends, and predictors of stroke after TAVI and evaluate the outcomes of patients with stroke. Methods and Results: The CENTER-Collaboration is an international collaboration consisting of 3 national registries and 7 local registries or prospective clinical trials, selected through a systematic review. Accordingly, a total of 10 982 patients undergoing transfemoral TAVI between 2007 and 2018 were included in the current patient-level pooled analyses. A total of 261 patients (2.4%) experienced stroke during the first month after TAVI. The median time between TAVI and stroke was 1 day (interquartile range, 0–6 days). The stroke rate was comparable in procedures performed in the early years of TAVI (2007–2012) to those in the more recent years of TAVI (2013–2018; both 2.4%; P =1.0). Independent predictors of stroke at 30 days were a history of cerebrovascular events (odds ratio, 2.2; 95% CI, 1.4–3.6; P =0.0012) and a glomerular filtration rate of <30 mL/min per 1.73 m 2 (odds ratio, 1.7; 95% CI, 1.0–2.8; P =0.05). Stroke occurring within the first 30 days after TAVI was associated with a 6-fold increase of 30-day mortality (odds ratio, 6.0; 95% CI, 4.4–8.1; P <0.001). Moreover, patients with stroke more frequently had documented new-onset atrial fibrillation (16% versus 3%; P <0.001) and major or life-threatening bleedings (12% versus 7%; P =0.002) at 30-day follow-up. Conclusions: In this large, global, patient-level analysis, the incidence of stroke after transfemoral TAVI was 2.4%. Prior cerebrovascular events and a low glomerular filtration rate independently predicted the occurrence of stroke after TAVI. The occurrence of stroke after TAVI was associated with a strikingly 6-fold increase of 30-day mortality; additionally, there was a 5-fold higher rate of new-onset atrial fibrillation in patients with stroke. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03588247.

1 August 2017 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
VAVincent Auffret
Vincent Auffret
JWJohn G. Webb
John G. Webb
HEHélène Eltchaninoff
Hélène Eltchaninoff
AMAntonio J. Muñoz-García
Antonio J. Muñoz-García
DHDominique Himbert
Dominique Himbert
JRJosep Rodés-Cabau
Josep Rodés-Cabau

15 December 2014 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
FBFábio S. de Brito
Fábio S. de Brito
LCLuiz A. Carvalho
Luiz A. Carvalho
RSRogério Sarmento‐Leite
Rogério Sarmento‐Leite
JMJosé A. Mangione
José A. Mangione
PLPedro Lemos
Pedro Lemos
OIon behalf of the Brazilian TAVI Registry investigators
on behalf of the Brazilian TAVI Registry investigators

1 November 2015 in JACC
Verified
Journal Article
Closed access
HRHenrique Ribeiro
Henrique Ribeiro
LNLuis Nombela-Franco
Luis Nombela-Franco
AMAntonio J. Muñoz-García
Antonio J. Muñoz-García
PLPedro Alves Lemos
Pedro Alves Lemos
IAIgnacio Amat-Santos
Ignacio Amat-Santos
JRJosep Rodés-Cabau
Josep Rodés-Cabau

1 August 2016 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
FBFernando L.M. Bernardi
Fernando L.M. Bernardi
HRHenrique Ribeiro
Henrique Ribeiro
LCLuiz A. Carvalho
Luiz A. Carvalho
RSRogerio Sarmento-Leite
Rogerio Sarmento-Leite
JMJosé A. Mangione
José A. Mangione
FBFábio S. de Brito
Fábio S. de Brito
Background—: Direct transcatheter aortic valve replacement (TAVR) is regarded as having potential advantages over TAVR with balloon aortic valve predilatation (BAVP) in reducing procedural complications, but there are few data to support this approach. Methods and Results—: Patients included in the Brazilian TAVR registry with CoreValve and Sapien-XT prosthesis were compared according to the implantation technique, with or without BAVP. Clinical and echocardiographic data were analyzed in overall population and after propensity score matching. A total of 761 consecutive patients (BAVP=372; direct-TAVR=389) were included. Direct-TAVR was possible in 99% of patients, whereas device success was similar between groups (BAVP=81.2% versus direct-TAVR=78.1%; P =0.3). No differences in clinical outcomes at 30 days and 1 year were observed, including all-cause mortality (7.6% versus 10%; P =0.25 and 18.1% versus 24.5%; P =0.07, respectively) and stroke (2.8% versus 3.8%; P =0.85 and 5.5% versus 6.8%; P =0.56, respectively). Nonetheless, TAVR with BAVP was associated with a higher rate of new onset persistent left bundle branch block with the CoreValve (47.7% versus 35.1%; P =0.01 at 1 year). Mean gradient and incidence of moderate/severe aortic regurgitation were similar in both groups at 1 year (11% versus 13.3%; P =0.57 and 9.8±5.5 versus 8.7±4.3; P =0.09, respectively). After propensity score matching analysis, all-cause mortality and stroke remained similar. By multivariable analysis, BAVP and the use of CoreValve were independent predictors of new onset persistent left bundle branch block. Conclusions—: The 2 TAVR strategies, with or without BAVP, provided similar clinical and echocardiographic outcomes over a midterm follow-up although BAVP was associated with a higher rate of new onset persistent left bundle branch block, particularly in patients receiving a CoreValve.